ESC 365 - Doxorubicin induces measurable vascular toxicity: assessment in a clinical and preclinical study

CBS PREMIUM ACCESS

Doxorubicin induces measurable vascular toxicity: assessment in a clinical and preclinical study

Session: Young Investigator Award - Novelties in cardiovascular disease mechanism

Topic: Biomarkers

Speaker: Mr M. Bosman (Antwerp, BE)

Event: Frontiers in CardioVascular Biomedicine 2022

Congress Presentation

Add to my library

About the speaker

Mr Matthias Bosman

University of Antwerp, Antwerp (Belgium)

0 follower

3 more presentations in this session

Modified mRNA delivery to the heart using Lipid Nanoparticles

Speaker: Ms M. Labonia (Utrecht, NL)

Intravital & laser speckle investigations of the role of interleukin36 in myocardial ischaemia reperfusion injury; a new therapeutic target for the aged heart

Speaker: Mr J. El-Awaisi (Birmingham, GB)

Effective revascularization of non-healing wounds by the human Stromal Vascular Fraction relies on direct cell integration and paracrine signals

Speaker: Mr R. Vuerich (Trieste, IT)

Access the full session

Young Investigator Award - Novelties in cardiovascular disease mechanism

Speakers: Mr M. Bosman, Ms M. Labonia, Mr J. El-Awaisi, Mr R. Vuerich

About the event

Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources